MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

August 2003



Editorial Board Spotlight: Thomas Biancaniello, MD

Sonja Sherritze

FDA Update

Drug Safety Revisions

Dr. Goldenberg presents the latest labeling changes for atorvastatin (Lipitor®), risperidone (Risperdal®), Gynecare Intergel Adhesion Prevention Solution® to heal adhesions after gynecological surgery, and lindane (Kwell®) to treat lice and scabies.
Marvin M. Goldenberg, PhD, RPh, MS

Principles of Antibiotic Formulary Selection for P&T Committees, Part 3: Antibiotic Resistance

Dr. Cunha describes natural and acquired resistance to antimicrobial agents and effective strategies to control this growing problem.
Burke A. Cunha, MD

Highlights of the 39th Annual Meeting of the American Society of Clinical Oncology

Dr. Prescott discusses advances in the treatment of breast, pancreatic, and colorectal cancers; bronchoalveolar cell carcinoma; refractory cancers; melanoma; non-Hodgkin’s lymphoma; leukemia; and chemotherapy-induced anemia.
Lawrence M. Prescott, PhD

Continuing Education Credit

Antiretroviral Therapy in HIV-Infected Adults, Part 1

The authors review the armamentarium of medications used to treat AIDS and HIV infection.
Eli Korner, PharmD, MPH, Mary Ellen Bonk, PharmD, Thomas Ratko, PhD, and Karl Matuszewski, MS, PharmD



Medicare Drug Coverage: LMRP, CAC, and NCD

Editor-in-Chief David Nash, MD, MBA, translates some new acronyms used in drug coverage under Medicare: LMRP, CAC, and NCD.
David B. Nash, MD, MBA

Medication Errors

Measuring Medication Safety: What Works? What Doesn’t?

Matthew Grissinger discusses ways to measure the effectiveness and safety of medication use.

Prescription: Washington

Pharmacy Residency Programs Endangered

Stephen Barlas describes possible changes in Medicare’s reimbursements to hospitals with pharmacist residency programs.

Drug News

New Drugs/Drug News

P&T presents the latest information about approvals, indication changes, industry updates, and news from the FDA.

Drug Forecast

Adalimumab: The First Entirely Human Monoclonal Antibody for Rheumatoid Arthritis

Drs. Mack and Neely review adalimumab (Humira®) for the treatment of rheumatoid arthritis.
Alicia Mack, PharmD, and Jessica Neely, PharmD

P&T Snapshot

The Changing Face of AIDS